Table 1. General characteristics of the studies.
Author and year of publication | Study region | Study period | Design of study | TB annual incidence rate per 100 000 inhabitants | Study duration (months) | Number of genotyped subjects | Sampling fraction (%) | DM diagnosis based on: | Primary genotyping method | Secondary genotyping method | Application of secondary genotyping method | Cluster definition | Index case of the cluster | Subjects in the cluster (%) | Contact tracing |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hernández-Garduño et al., 2002 [55]. | Greater Vancouver, British Columbia, Canada | 1995–1999 | Cohort | 6.0** | 50 | 793 | 100 | Information obtained from the dataset of the TB division. | RFLP-IS6110 | Spoligotyping | < 6 copies of IS6110 | ≥ 2 strains with identical DNA (≥ 6 copies with RFLP, or < 6 copies with s poligotyping | First diagnosed patient | 17.3 | Yes |
Borrell et al., 2010 [21].* | Barcelona, Spain | 2003–2004 | Cohort | 21.6 | 24 | 115 | 67.4 | Information obtained from TB program dataset of Barcelona and microbiology areas of hospitals and clinical centers. | RFLP-IS6110 | MIRU-12 loci | < 6 copies of IS6110 or ≥6 bands with a different one | ≥ 2 patients: (i) RFLP-IS6110 ≥ 6 bands in the same position; (ii) RFLP-IS6110 < 6 bands in the same position but with identical MIRU-12 loci; (iii) RFLP-IS6110 ≥ 6 bands that differ in 1 band but with identical MIRU-12 loci | Subject with earliest onset of pulmonary symptoms or the one that started treatment first (asymptomatic) | 32 | Unknown |
Jiménez-Corona et al., 2013 [56]. | Orizaba, Veracruz, México | 1995–2010 | Cohort | 21** | 181 | 1013 | 80 | Previous diagnosis from a physician or oral hypoglycemic medication or insulin administration or treatment | RFLP-IS6110 | Spoligotyping | < 6 copies of IS6110 | ≥ 2 two or more isolates from different patients identified within 12 months of each other and with six or more IS6110 bands in an identical pattern, or < 6 bands with identical IS6110 RFLP patterns and a spoligotype with the same spacer oligonucleotides | Not specified | 28.8 | Unknown |
Wang et al., 2014 [57]. | Beijing, China | 2009–2011 | Cohort | 73** | 48 | 115 | 100 | Clinical data obtained from the patient`s medical history | MIRU-VNTR 24 loci (up to 28) | Does not apply | Does not apply | ≥ 2 strains showing identical patterns MIRU-VNTR | Not specified | 17.4 | Unknown |
González et al., 2015 [54]. | La Habana, Cuba | 2009 | Cohort | 8.2 | 12 | 59 | 61 | Clinical information obtained from the national statistics / epidemiology data base of the public health ministry of Cuba | MIRU-VNTR 24 loci | Does not apply | Does not apply | Strains with identical genetic pattern | Not specified | 54.2 | Yes |
Yang et al., 2015 [58]. | China | 2009–2012 | Cohort | 73** | 36 | 1948 | 82 | Clinical information obtained by professional interviewers with standardized questionnaire. | MIRU-VNTR 29 loci | Does not apply | Does not apply | Strains with identical genetic pattern | First patient in the cluster | 31 | Yes |
*We used only information from foreign patients;
** Annual rates were taken from World Bank [18]